{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:00:56Z","timestamp":1789642856672,"version":"4.0.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1124\/molpharm.121.000266","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T14:05:13Z","timestamp":1621001113000},"page":"46-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Molecular Determinants Underlying Delta Selective Compound 2 Activity at \u03b4-Containing GABAA Receptors"],"prefix":"10.1016","volume":"100","author":[{"given":"Christina B.","family":"Falk-Petersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Rostrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekka","family":"L\u00f6ffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stine","family":"Buchleithner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasper","family":"Harps\u00f8e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Gloriam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente","family":"Fr\u00f8lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petrine","family":"Wellendorph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/molpharm.121.000266_bib1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.phrs.2016.05.014","article-title":"A pharmacological assessment of agonists and modulators at \u03b14\u03b22\u03b32 and \u03b14\u03b22\u03b4 GABAA receptors: The challenge in comparing apples with oranges","volume":"111","author":"Ahring","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1124\/molpharm.121.000266_bib2","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1124\/mol.107.042481","article-title":"Atomic force microscopy reveals the stoichiometry and subunit arrangement of the \u03b14\u03b23\u03b4 GABA(A) receptor","volume":"73","author":"Barrera","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/molpharm.121.000266_bib3","doi-asserted-by":"crossref","first-page":"46020","DOI":"10.1074\/jbc.M207663200","article-title":"Forced subunit assembly in \u03b11\u03b22\u03b32 GABAA receptors. Insight into the absolute arrangement","volume":"277","author":"Baumann","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.121.000266_bib4","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1471-4159.2009.06387.x","article-title":"Structure of \u03b16 \u03b23 \u03b4 GABA(A) receptors and their lack of ethanol sensitivity","volume":"111","author":"Baur","year":"2009","journal-title":"J Neurochem"},{"key":"10.1124\/molpharm.121.000266_bib5","doi-asserted-by":"crossref","first-page":"12757","DOI":"10.1523\/JNEUROSCI.3340-09.2009","article-title":"Extrasynaptic GABAA receptors: form, pharmacology, and function","volume":"29","author":"Belelli","year":"2009","journal-title":"J Neurosci"},{"key":"10.1124\/molpharm.121.000266_bib6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09511","article-title":"Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke","volume":"468","author":"Clarkson","year":"2010","journal-title":"Nature"},{"key":"10.1124\/molpharm.121.000266_bib7","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/nm.2058","article-title":"Enhanced tonic GABAA inhibition in typical absence epilepsy","volume":"15","author":"Cope","year":"2009","journal-title":"Nat Med"},{"key":"10.1124\/molpharm.121.000266_bib8","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1111\/bph.15146","article-title":"Silencing of spontaneous activity at \u03b14\u03b21\/3\u03b4 GABAA receptors in hippocampal granule cells reveals different ligand pharmacology","volume":"177","author":"Dalby","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1124\/molpharm.121.000266_bib9","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1124\/mol.105.015982","article-title":"Comparative models of GABAA receptor extracellular and transmembrane domains: important insights in pharmacology and function","volume":"68","author":"Ernst","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/molpharm.121.000266_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/bcpt.12778","article-title":"Development of a robust mammalian cell-based assay for studying recombinant \u03b14\u03b21\/3\u03b4 GABAA receptor subtypes","volume":"121","author":"Falk-Petersen","year":"2017","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1124\/molpharm.121.000266_bib11","doi-asserted-by":"crossref","first-page":"10078","DOI":"10.1038\/s41598-020-66821-0","article-title":"Discovery of a new class of orthosteric antagonists with nanomolar potency at extrasynaptic GABAA receptors","volume":"10","author":"Falk-Petersen","year":"2020","journal-title":"Sci Rep"},{"key":"10.1124\/molpharm.121.000266_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrn1625","article-title":"Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors","volume":"6","author":"Farrant","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/molpharm.121.000266_bib13","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1213\/ANE.0000000000001368","article-title":"Mapping general anesthetic sites in heteromeric \u03b3-aminobutyric acid type A receptors reveals a potential for targeting receptor subtypes","volume":"123","author":"Forman","year":"2016","journal-title":"Anesth Analg"},{"key":"10.1124\/molpharm.121.000266_bib14","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/sj.bjp.0700927","article-title":"Subunit-dependent interaction of the general anaesthetic etomidate with the gamma-aminobutyric acid type A receptor","volume":"120","author":"Hill-Venning","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1124\/molpharm.121.000266_bib15","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.neuropharm.2009.12.023","article-title":"Pharmacological characterization of a novel positive modulator at \u03b1 4 \u03b2 3 \u03b4-containing extrasynaptic GABA(A) receptors","volume":"58","author":"Hoestgaard-Jensen","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1124\/molpharm.121.000266_bib16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/ijms21010334","article-title":"GABAA receptor ligands often interact with binding sites in the transmembrane domain and in the extracellular domain-can the promiscuity code be cracked?","volume":"21","author":"Iorio","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1124\/molpharm.121.000266_bib17","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/bph.12001","article-title":"A study of subunit selectivity, mechanism and site of action of the delta selective compound 2 (DS2) at human recombinant and rodent native GABA(A) receptors","volume":"168","author":"Jensen","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1124\/molpharm.121.000266_bib18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bcp.2012.05.017","article-title":"Low nanomolar GABA effects at extrasynaptic \u03b14\u03b21\/\u03b23\u03b4 GABA(A) receptor subtypes indicate a different binding mode for GABA at these receptors","volume":"84","author":"Karim","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/molpharm.121.000266_bib19","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.1074\/jbc.M806484200","article-title":"Unanticipated structural and functional properties of \u03b4-subunit-containing GABAA receptors","volume":"284","author":"Kaur","year":"2009","journal-title":"J Biol Chem"},{"issue":"D1","key":"10.1124\/molpharm.121.000266_bib20","doi-asserted-by":"crossref","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","article-title":"PubChem 2019 update: improved access to chemical data","volume":"47","author":"Kim","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/molpharm.121.000266_bib21","doi-asserted-by":"crossref","first-page":"8846","DOI":"10.1021\/acsomega.9b00434","article-title":"Synthesis and pharmacological evaluation of [11C]4-methoxy-N-[2-(thiophen-2-yl)imidazo[1,2- a] pyridin-3-yl]benzamide as a brain penetrant PET ligand selective for the \u03b4-subunit-containing \u03b3-aminobutyric acid type A receptors","volume":"4","author":"L\u2019Estrade","year":"2019","journal-title":"ACS Omega"},{"key":"10.1124\/molpharm.121.000266_bib22","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-018-0833-4","article-title":"Cryo-EM structure of the human \u03b11\u03b23\u03b32 GABAA receptor in a lipid bilayer","volume":"565","author":"Laverty","year":"2019","journal-title":"Nature"},{"key":"10.1124\/molpharm.121.000266_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fncir.2014.00003","article-title":"The impact of tonic GABAA receptor-mediated inhibition on neuronal excitability varies across brain region and cell type","volume":"8","author":"Lee","year":"2014","journal-title":"Front Neural Circuits"},{"key":"10.1124\/molpharm.121.000266_bib24","doi-asserted-by":"crossref","first-page":"11599","DOI":"10.1523\/JNEUROSCI.3467-06.2006","article-title":"Identification of a GABAA receptor anesthetic binding site at subunit interfaces by photolabeling with an etomidate analog","volume":"26","author":"Li","year":"2006","journal-title":"J Neurosci"},{"key":"10.1124\/molpharm.121.000266_bib25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/0271678X17744123","article-title":"GAT3 selective substrate l-isoserine upregulates GAT3 expression and increases functional recovery after a focal ischemic stroke in mice","volume":"39","author":"Lie","year":"2019","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1124\/molpharm.121.000266_bib26","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41586-018-0832-5","article-title":"GABAA receptor signalling mechanisms revealed by structural pharmacology","volume":"565","author":"Masiulis","year":"2019","journal-title":"Nature"},{"key":"10.1124\/molpharm.121.000266_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1124\/mol.119.118927","article-title":"New author guidelines for displaying data and reporting data analysis and statistical methods in experimental biology","volume":"97","author":"Michel","year":"2020","journal-title":"Mol Pharmacol"},{"key":"10.1124\/molpharm.121.000266_bib28","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1023\/A:1012376215967","article-title":"Distinguishing between GABA(A) receptors responsible for tonic and phasic conductances","volume":"26","author":"Mody","year":"2001","journal-title":"Neurochem Res"},{"key":"10.1124\/molpharm.121.000266_bib29","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1113\/jphysiol.2009.182444","article-title":"Distinct activities of GABA agonists at synaptic- and extrasynaptic-type GABAA receptors","volume":"588","author":"Mortensen","year":"2010","journal-title":"J Physiol"},{"key":"10.1124\/molpharm.121.000266_bib30","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3389\/fnins.2019.01133","article-title":"The delta-subunit selective GABAA receptor modulator, DS2, improves stroke recovery via an anti-inflammatory mechanism","volume":"13","author":"Neumann","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1124\/molpharm.121.000266_bib31","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bcp.2018.02.015","article-title":"Delineation of the functional properties and the mechanism of action of AA29504, an allosteric agonist and positive allosteric modulator of GABAA receptors","volume":"150","author":"Olander","year":"2018","journal-title":"Biochem Pharmacol"},{"issue":"Pt A","key":"10.1124\/molpharm.121.000266_bib32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuropharm.2018.01.036","article-title":"GABAA receptor: positive and negative allosteric modulators","volume":"136","author":"Olsen","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1124\/molpharm.121.000266_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2008.07.045","article-title":"A receptors: subtypes provide diversity of function and pharmacology","volume":"56","author":"Olsen","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1124\/molpharm.121.000266_bib34","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/bph.12514","article-title":"Stoichiometry of \u03b4 subunit containing GABA(A) receptors","volume":"171","author":"Patel","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1124\/molpharm.121.000266_bib35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fnmol.2016.00044","article-title":"Structural studies of GABAA receptor binding sites: which experimental structure tells us what?","volume":"9","author":"Puthenkalam","year":"2016","journal-title":"Front Mol Neurosci"},{"key":"10.1124\/molpharm.121.000266_bib36","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1021\/acs.jmedchem.0c02163","article-title":"Structural determinants for the mode of action of the imidazopyridine DS2 at \u03b4-containing \u03b3-aminobutyric acid type A (GABAA) receptors","volume":"64","author":"Rostrup","year":"2021","journal-title":"J Med Chem"},{"key":"10.1124\/molpharm.121.000266_bib37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J Comput Aided Mol Des"},{"key":"10.1124\/molpharm.121.000266_bib38","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1476-5381.2011.01779.x","article-title":"A novel GABA(A) receptor pharmacology: drugs interacting with the \u03b1(+) \u03b2(-) interface","volume":"166","author":"Sieghart","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1124\/molpharm.121.000266_bib39","doi-asserted-by":"crossref","first-page":"40224","DOI":"10.1074\/jbc.R112.386664","article-title":"Structure, function, and modulation of GABA(A) receptors","volume":"287","author":"Sigel","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.121.000266_bib40","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1016\/j.bmc.2019.06.006","article-title":"Defined concatenated \u03b16\u03b11\u03b23\u03b32 GABAA receptor constructs reveal dual action of pyrazoloquinolinone allosteric modulators","volume":"27","author":"Simeone","year":"2019","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/molpharm.121.000266_bib41","doi-asserted-by":"crossref","first-page":"14439","DOI":"10.1073\/pnas.2435457100","article-title":"Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors","volume":"100","author":"Stell","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.121.000266_bib42","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1124\/jpet.105.092403","article-title":"Pharmacological characterization of agonists at \u03b4-containing GABAA receptors: functional selectivity for extrasynaptic receptors is dependent on the absence of \u03b32","volume":"316","author":"St\u00f3rustovu","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/molpharm.121.000266_bib43","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1523\/JNEUROSCI.17-08-02728.1997","article-title":"Stoichiometry and assembly of a recombinant GABAA receptor subtype","volume":"17","author":"Tretter","year":"1997","journal-title":"J Neurosci"},{"issue":"D1","key":"10.1124\/molpharm.121.000266_bib44","doi-asserted-by":"crossref","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: a worldwide hub of protein knowledge","volume":"47","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/molpharm.121.000266_bib45","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coph.2005.10.004","article-title":"Gaboxadol--a new awakening in sleep","volume":"6","author":"Wafford","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"10.1124\/molpharm.121.000266_bib46","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2008.08.004","article-title":"Novel compounds selectively enhance \u03b4 subunit containing GABA A receptors and increase tonic currents in thalamus","volume":"56","author":"Wafford","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1124\/molpharm.121.000266_bib47","doi-asserted-by":"crossref","first-page":"14187","DOI":"10.1074\/jbc.M110.104257","article-title":"Stoichiometry of expressed \u03b1(4)\u03b2(2)\u03b4 \u03b3-aminobutyric acid type A receptors depends on the ratio of subunit cDNA transfected","volume":"285","author":"Wagoner","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.121.000266_bib48","doi-asserted-by":"crossref","first-page":"5.6.1","DOI":"10.1002\/cpbi.3","article-title":"Comparative protein structure modeling using MODELLER","volume":"54","author":"Webb","year":"2016","journal-title":"Curr Protoc Bioinforma"},{"key":"10.1124\/molpharm.121.000266_bib49","doi-asserted-by":"crossref","first-page":"18474","DOI":"10.1074\/jbc.M116.738906","article-title":"Toward understanding functional properties and subunit arrangement of \u03b14\u03b22\u03b4 \u03b3-aminobutyric Acid, Type A (GABAA) receptors","volume":"291","author":"Wongsamitkul","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.121.000266_bib50","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/acs.jmedchem.7b01484","article-title":"Structure-function evaluation of imidazopyridine derivatives selective for \u03b4-subunit-containing \u03b3-aminobutyric acid type A (GABAA) receptors","volume":"61","author":"Yakoub","year":"2018","journal-title":"J Med Chem"},{"key":"10.1124\/molpharm.121.000266_bib51","doi-asserted-by":"crossref","first-page":"L406","DOI":"10.1152\/ajplung.00107.2017","article-title":"GABAA receptor \u03b14-subunit knockout enhances lung inflammation and airway reactivity in a murine asthma model","volume":"313","author":"Yocum","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1124\/molpharm.121.000266_bib52","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.expneurol.2017.08.008","article-title":"Decreased surface expression of the \u03b4 subunit of the GABAA receptor contributes to reduced tonic inhibition in dentate granule cells in a mouse model of fragile X syndrome","volume":"297","author":"Zhang","year":"2017","journal-title":"Exp Neurol"},{"key":"10.1124\/molpharm.121.000266_bib53","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41586-018-0255-3","article-title":"Structure of a human synaptic GABAA receptor","volume":"559","author":"Zhu","year":"2018","journal-title":"Nature"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X2401157X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X2401157X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/molpharm.121.000266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T08:46:53Z","timestamp":1739954813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X2401157X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0026895X2401157X"],"URL":"https:\/\/doi.org\/10.1124\/molpharm.121.000266","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Determinants Underlying Delta Selective Compound 2 Activity at \u03b4-Containing GABAA Receptors","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/molpharm.121.000266","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}